IA
BIAF icon

IFP Advisors’s bioAffinity Technologies BIAF Stock Holding History

IFP Advisors’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$676 Hold
833
– – ﹤0.01% 4613
2026
Q1 		$3.19K Hold
833
– – ﹤0.01% 3773
2025
Q4 		$983 Sell
833
-25,000
-97% -$49.8K ﹤0.01% 4076
2025
Q3 		$6.69K Buy
25,833
+25,000
+3,001% +$199K ﹤0.01% 3098
2025
Q2 		$7.18K Buy
833
+333
+67% +$3.81K ﹤0.01% 3118
2025
Q1 		$3.9K Buy
500
+167
+50% +$3.06K ﹤0.01% 2928
2024
Q4 		$9.1K Hold
333
– – ﹤0.01% 2558
2024
Q3 		$20.8K Hold
333
– – ﹤0.01% 2130
2024
Q2 		$21.6K Buy
333
+166
+99% +$11.5K ﹤0.01% 2047
2024
Q1 		$10.1K Hold
167
– – ﹤0.01% 2232
2023
Q4 		$7.35K Buy
+167
New +$7.14K ﹤0.01% 2292

Other funds holding BIAF

JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

IFP Advisors's BIAF Position: Q2 2026 in Review

IFP Advisors held its bioAffinity Technologies (BIAF) position steady in Q2 2026 at 833 shares worth $676. The position accounts for ﹤0.01% of the portfolio, ranked #4613.

IFP Advisors first reported a position in BIAF in Q4 2023 and has held it in 11 quarters since. The position peaked at $21.6K in Q2 2024. 14 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

  • IFP Advisors held 833 shares of bioAffinity Technologies worth $676 as of Q2 2026.
  • IFP Advisors left its bioAffinity Technologies share count unchanged in Q2 2026.
  • bioAffinity Technologies made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4613 holding.
  • IFP Advisors first reported a position in bioAffinity Technologies in Q4 2023 and has held it in 11 quarters since.
  • IFP Advisors's bioAffinity Technologies position peaked at $21.6K in Q2 2024.
  • 14 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.